OBJECTIVE: We retrospectively examined the effect of combination therapy with
prednisolone and cyclosporin A (CSA) for dermatomyositis (DM) presenting with acute/subacute …

Objectives: We retrospectively investigated clinical prognostic factors for interstitial
pneumonia (IP) in anti-melanoma differentiation-associated gene 5 (MDA5) antibody (Ab)-positive …

We retrospectively examined the effect of combination therapy with prednisolone and
cyclosporin-A (CSA) on the findings of pulmonary function tests (PFTs) and chest high-resolution …

Objectives To elucidate the serum cytokine profile and address the pathomechanism of
interstitial lung disease (ILD) complicated with PM/DM. Methods Forty patients with PM/DM-ILD …

Background Acute/subacute interstitial pneumonia in dermatomyositis (DM-A/SIP) is a disease
associated with a poor prognosis that resists treatment with glucocorticosteroids (GC) and …

The aim of this study was to investigate long-term prognosis and relapse of dermatomyositis
complicated with interstitial pneumonia (DMIP) according to anti-aminoacyl tRNA …

Objectives Microscopic polyangiitis (MPA) is often complicated by interstitial lung disease (ILD);
however, biomarkers that can be used to diagnose and predict the progression of MPA-…

Dermatomyositis (DM) is frequently complicated by interstitial lung disease (ILD), which
increases mortality. This study aims to elucidate the clinical significance of nailfold …

Chemokines play an important role in the pathophysiology of dermatomyositis (DM) with
interstitial pneumonia (IP). However, the relation between chemokines and the disease activity …

The prognosis of microscopic polyangiitis (MPA) with interstitial lung disease (ILD) is
significantly worse than that of MPA without ILD. However, the clinical characteristics in MPA-ILD, …